mefloquine is used to both prevent and treat certain forms of malaria mefloquine is useful for the prevention of malaria in all areas except for those where parasites may have resistance to multiple medications , and is one of several anti-malarial medications recommended by the united states centers for disease control and prevention for this purpose it is also recommended by the infectious disease society of america for malaria prophylaxis as a first or second-line agent , depending on resistance patterns in the malaria found in the geographic region visited doxycycline and atovaquone/proguanil provide protection within one to two days and may be better tolerated if a person becomes ill with malaria despite prophylaxis with mefloquine , the use of halofantrine and quinine for treatment may be ineffective it is one of several drugs recommended by the united states ' centers for disease control and prevention food and drug administration ( fda ) added a boxed warning to the prescription label of mefloquine regarding the potential for neuropsychiatric side effects that may persist even after discontinuing administration of the medication in 2013 the fda stated '' neurologic side effects can occur at any time during drug use , and can last for months to years after the drug is stopped or can be permanent central nervous system events requiring hospitalization occur in about one in 10,000 people taking mefloquine for malaria prevention , with milder events ( e.g available data suggests that mefloquine is safe and effective for use by pregnant women during all trimesters of pregnancy , and it is widely used for this indication compared to other malaria chemoprophylaxis regimens , however , mefloqinone may produce more side effects in non-pregnant travelers mefloquine is also safe and effective for use during breastfeeding , though it appears in breast milk in low concentrations because of the drug 's very long half-life , the centers for disease control originally recommended a mefloquine dosage of 250 & nbsp ; mg every two weeks ; however , this caused an unacceptably high malaria rate in the peace corps volunteers who participated in the approval study , so the drug regimen was switched to once a week by 1994 , medical professionals were noting '' severe psychiatric side effects observed during prophylaxis and treatment with mefloquine '' , and recommending that '' the absence of contraindications and minor side effects during an initial course of mefloquine should be confirmed before another course is prescribed in the mefloquine arm , 5 % of the users reported severe events requiring medical attention , vs 1.2 % in the atovaquone-proguanil arm in 2006 , the australian military deemed mefloquine '' a third-line drug '' alternative , and over the five years from 2011 only 25 soldiers had been prescribed the drug , and only in cases of their intolerance for other alternatives 